THERASPAN Trademark

Trademark Overview


On Monday, March 30, 2020, a trademark application was filed for THERASPAN with the United States Patent and Trademark Office. The USPTO has given the THERASPAN trademark a serial number of 88853351. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 31, 2021. This trademark is owned by GanD, Inc.. The THERASPAN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of shock, hypovolemia, hemorrhage, sepsis, dehydration, dysentery, diarrhea, vomiting, ketoacidosis, fever, pneumonia, burns, epithelial injury, endothelial injury, metabolic dysfunction, and for use for maintenance of fluid balance, fluid resuscitation, supportive care, electrolyte imbalance, delivery of pharmaceuticals, delivery of blood components or blood products, and for tissue and organ perfusion and preservation

Development of pharmaceutical preparations and medicines; Pharmaceutical research and development
theraspan

General Information


Serial Number88853351
Word MarkTHERASPAN
Filing DateMonday, March 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 31, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for treatment of shock, hypovolemia, hemorrhage, sepsis, dehydration, dysentery, diarrhea, vomiting, ketoacidosis, fever, pneumonia, burns, epithelial injury, endothelial injury, metabolic dysfunction, and for use for maintenance of fluid balance, fluid resuscitation, supportive care, electrolyte imbalance, delivery of pharmaceuticals, delivery of blood components or blood products, and for tissue and organ perfusion and preservation
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGanD, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami Beach, FL 33139

Party NameGanD, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami Beach, FL 33139

Trademark Events


Event DateEvent Description
Tuesday, June 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 31, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 27, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION WRITTEN
Thursday, June 18, 2020ASSIGNED TO EXAMINER
Monday, April 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 2, 2020NEW APPLICATION ENTERED IN TRAM